results of the RTOG randomised trial. Lancet. 2004; 363:1665–1672.
Andrews DW, Scott CB, Sperduto PW. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG randomised trial. Lancet. 2004; 363: 1665–1672.
Aoyama H, Shirato H, Tago M. Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006; 295:2483–2491.
Ewend MG, Brem S, Gilbert M. Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control. Clin Cancer Res 2007; 13:3637–41.
Kocher M, Soffietti R, Abacioglu UAdjuvant. Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study. J Clin Oncol. .2011; 29(2):121-124.
Meyers CA, Smith JA, Bezjak A. Neurocognitive function and progression in patients with brain metastases treated with whole brain radiation and motexafin gadolinium: results of a randomized phase III trial. Journal of Clinical Oncology 2004; 22:157–165.
Sperduto PW, Berkey B, Gaspar LE. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008; 70:510– 4.
Duong AV, Dirk R. Busse R.Extracranial metastatic patterns on occurrence of brain metastases.Journal of Neuro-Oncology October 2011; 105, (1):83-90.
Staudt M, Lasithiotakis K, Leiter U, Meier F. Determinants of survival in patients with brain metastases from cutaneous melanoma British Journal of Cancer 2010;10:1213–1218. [en linia] Disponible en : http://www.bjcancer.com/
Orazio Caffo, Antonello Veccia, Gianni Fellin, Salvatore Mussari .Frequency of brain metastases from prostate cancer: an 18-year single-institution experience. .Journal of Neuro-Oncology 2013 ;( 2):163-167.
Nieder, Carsten, Adam Pawinski, and Lise Balteskard. “Colorectal cancer metastatic to the brain: time trends in presentation and outcome.” Oncology 2009; 76(5):369-374.
Sartor AO, Oudard S, Ozguroglu M, Hansen S, Machiels JH, Shen L, et al. Survival benefit from first docetaxel treatment for cabazitaxel plus prednisone compared with mitoxantrone plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in the TROPIC trial. J Clin Oncol 2011; 29(suppl): abs 4525.
Giuseppe Aprile, Zanon E, Tuniz F, Iaiza Emiliana, De Pauli F, Pella Nicoletta, et al. “Neurosurgical management and postoperative whole-brain radiotherapy for colorectal cancer patients with symptomatic brain metastases.” Journal of Cancer Research and Clinical Oncology 2009; 135(3):451-457.
Cascino TL, Leavengood JM, Kemeny N, Posner JB: Brain metastases from colon cancer. J Neurooncol 1983; 1:203-209.
Farnell G, Buckner J, Cascino T, O’Connell M, Schomberg P, Suman V. Brain metastases from colorectal carcinoma: the long term survivors. Cancer, 1996; 78:711-716.
Hammoud MA, McCutcheon IE, Elsouki R, Schoppa D, and Patt YZ. “Colorectal carcinoma and brain metastasis: distribution, treatment, and survival.” Annals of Surgical Oncology 1996; 3(5):453-463.
Ishikura A, Hunaki N, Watanabe K: Brain metastasis of colorectal cancer: a case report. Gan No Rinsho 1987; 33:188-192.
Patel AJ, Suki D, Hatiboglu MA, Abouassi H, Shi W, Wildrick DM, Lang FF and Sawaya R (2010) Factors influencing the risk of local recurrence after resection of a single brain metastasis J Neurosurg 113(2) 181–9
Rades D, Raabe A, Bajrovic A, Alberti W: Treatment of solitary brain metastasis. Resection followed by whole brain radiation therapy (WBRT) and a radiation boost to the metastatic site. Strahlenther Onkol, 2004; 180:144-147.
Üskent y col. Survival from the precocious brain metastasis of the colon cancer Turkish Journal of Cancer 2003;33(3) [en linia] Disponible en :http://www.turkjcancer.org/pdf/pdf_TJC_348.pdf
Spread of colon cancer. In: De Vita. Cancer, principles and practice of oncology. Philadelphia: LippincottWilliams, 2001; 1229-3